86 results
8-K
EX-99.1
MAIA
MAIA Biotechnology Inc
6 Jun 24
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
2:57pm
extending patient survival and establishing a new standard of care for cancer.
“We remain steadfast in our goals for responsible access to capital. We
8-K
EX-10.1
MAIA
MAIA Biotechnology Inc
23 Apr 24
MAIA Biotechnology Announces $1.00 Million Private Placement
4:05pm
the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any … any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way
8-K
EX-4.1
cd97pz
23 Apr 24
MAIA Biotechnology Announces $1.00 Million Private Placement
4:05pm
8-K
EX-4.1
efj1t2xza3ou6qwudx
26 Mar 24
MAIA Biotechnology Announces $1.33 Million Private Placement
3:36pm
8-K
EX-10.1
wwdi5 dvw1
26 Mar 24
MAIA Biotechnology Announces $1.33 Million Private Placement
3:36pm
8-K
EX-10.1
rns9q
13 Mar 24
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-99.1
8ux2gpsg6vv
27 Feb 24
MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor
5:23pm
8-K
EX-1.1
xbgvxmwt
14 Feb 24
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-4.2
2bnodq0ri 2gho4gkn
17 Nov 23
MAIA Biotechnology Announces $4 Million Registered Direct Offering
9:09am
8-K
EX-4.1
ymh681w2vvul istq7
17 Nov 23
MAIA Biotechnology Announces $4 Million Registered Direct Offering
9:09am
8-K
EX-10.1
k7dgxdbjys
17 Nov 23
MAIA Biotechnology Announces $4 Million Registered Direct Offering
9:09am
8-K
EX-4.1
sorvajq181hc
16 Nov 23
Entry into a Material Definitive Agreement
5:26pm